| Characterizing a thermostable Cas9 for bacterial genome editing and silencing I Mougiakos, P Mohanraju, EF Bosma, V Vrouwe, M Finger Bou, ... Nature communications 8 (1), 1647, 2017 | 182 | 2017 |
| Next generation prokaryotic engineering: the CRISPR-Cas toolkit I Mougiakos, EF Bosma, WM de Vos, R van Kranenburg, J van der Oost Trends in biotechnology 34 (7), 575-587, 2016 | 150 | 2016 |
| Hijacking CRISPR-Cas for high-throughput bacterial metabolic engineering: advances and prospects I Mougiakos, EF Bosma, J Ganguly, J van der Oost, R van Kranenburg Current Opinion in Biotechnology 50, 146-157, 2018 | 92 | 2018 |
| Efficient genome editing of a facultative thermophile using mesophilic spCas9 I Mougiakos, EF Bosma, K Weenink, E Vossen, K Goijvaerts, ... ACS synthetic biology 6 (5), 849-861, 2017 | 88 | 2017 |
| Cas12a2 elicits abortive infection through RNA-triggered destruction of dsDNA O Dmytrenko, GC Neumann, T Hallmark, DJ Keiser, VM Crowley, ... Nature 613 (7944), 588-594, 2023 | 67 | 2023 |
| Efficient Cas9-based genome editing of Rhodobacter sphaeroides for metabolic engineering I Mougiakos, E Orsi, MR Ghiffary, W Post, A de Maria, B Adiego-Perez, ... Microbial cell factories 18 (1), 204, 2019 | 38 | 2019 |
| Rapid cell-free characterization of multi-subunit CRISPR effectors and transposons F Wimmer, I Mougiakos, F Englert, CL Beisel Molecular Cell 82 (6), 1210-1224. e6, 2022 | 24 | 2022 |
| Growth-uncoupled isoprenoid synthesis in Rhodobacter sphaeroides E Orsi, I Mougiakos, W Post, J Beekwilder, M Dompè, G Eggink, ... Biotechnology for Biofuels 13 (1), 123, 2020 | 22 | 2020 |
| Development of a Cas12a-based genome editing tool for moderate thermophiles P Mohanraju, I Mougiakos, J Albers, M Mabuchi, RT Fuchs, JL Curcuru, ... The CRISPR journal 4 (1), 82-91, 2021 | 19 | 2021 |
| A hyperthermoactive-Cas9 editing tool reveals the role of a unique arsenite methyltransferase in the arsenic resistance system of Thermus thermophilus HB27 G Gallo, I Mougiakos, M Bianco, M Carbonaro, A Carpentieri, A Illiano, ... MBio 12 (6), e02813-21, 2021 | 15 | 2021 |
| First structural insights into CRISPR-Cas-guided DNA transposition J van der Oost, I Mougiakos Cell Research 30 (3), 193-194, 2020 | 8 | 2020 |
| Efficient genome and base editing in human cells using ThermoCas9 D Trasanidou, P Barendse, E Bouzetos, L de Haan, H Bouwmeester, ... The CRISPR Journal 6 (3), 278-288, 2023 | 7 | 2023 |
| Thermostable Cas9 nucleases J Van Der Oost, R Van Kranenburg, EF Bosma, I Mougiakos US Patent 11,242,513, 2022 | 5 | 2022 |
| Transmissible elements comprising pathway modification systems and exogenous nucleic acids for the production of molecules of interest J LE MIÈRE, E SØNDBERG, S SEMSEY, I Mougiakos US Patent App. 18/763,680, 2025 | 4 | 2025 |
| Novel type of crispr/cas system S SEMSEY, I Mougiakos, E SØNDBERG, J Clube US Patent App. 18/753,324, 2025 | 4 | 2025 |
| Thermostable Cas9 nucleases J Van Der Oost, R Van Kranenburg, EF Bosma, I Mougiakos, P Mohanraju US Patent 11,326,162, 2022 | 4 | 2022 |
| Cas12a2 elicits abortive infection via RNA-triggered destruction of double-stranded DNA O Dmytrenko, GC Neumann, T Hallmark, DJ Keiser, VM Crowley, ... bioRxiv, 2022.06. 13.495973, 2022 | 3 | 2022 |
| CRISPR transposons on the move I Mougiakos, CL Beisel Cell Host & Microbe 29 (5), 675-677, 2021 | 2 | 2021 |
| Thermostable Cas9 nucleases J Van Der Oost, R Van Kranenburg, EF Bosma, I Mougiakos, P Mohanraju US Patent 12,071,639, 2024 | 1 | 2024 |
| Characterization of the AcrIIC1 anti‒CRISPR protein for Cas9‒based genome engineering in E. coli D Trasanidou, A Potocnik, P Barendse, P Mohanraju, E Bouzetos, ... Communications Biology 6 (1), 1042, 2023 | 1 | 2023 |
